Operating Lease, Liability, Noncurrent of VERTEX PHARMACEUTICALS INC / MA from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • VERTEX PHARMACEUTICALS INC / MA Operating Lease, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $1,834,800,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,834,800,000 +$245,900,000 +15% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,527,400,000 +$940,600,000 +160% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,537,700,000 +$1,177,900,000 +327% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $1,544,400,000 +$1,195,800,000 +343% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $1,588,900,000 +$1,234,500,000 +348% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $586,800,000 +$223,300,000 +61% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $359,800,000 -$11,800,000 -3.2% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $348,600,000 -$30,900,000 -8.1% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $354,400,000 -$27,900,000 -7.3% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $363,500,000 -$1,500,000 -0.41% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $371,600,000 -$5,400,000 -1.4% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $379,500,000 +$2,100,000 +0.56% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $382,300,000 +$18,755,000 +5.2% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $365,000,000 -$3,924,000 -1.1% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $377,000,000 +$8,533,000 +2.3% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $377,400,000 +$26,900,000 +7.7% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q3 2021 $363,545,000 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $368,924,000 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $368,467,000 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $350,500,000 +$266,208,000 +316% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q4 2019 $84,292,000 +$19,443,000 +30% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 $62,978,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $60,433,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $63,484,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $64,849,000 01 Jan 2019 10-Q 31 Oct 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.